When BPH rats were treated with O. majorana at doses of 250 and 500 mg/kg/day, a significant reduction in the quantitative expression of TGF-β1 mRNA and protein was identified compared to the BPH group (Figure 5C,D). Here, TGFB1 is linked to benign prostatic hyperplasia.